Basit öğe kaydını göster

dc.contributor.authorAksoy, Ahmet
dc.contributor.authorGülcü, Anıl
dc.contributor.authorTuna, Mehmet Mert
dc.contributor.authorAslan, Ahmet
dc.date.accessioned2023-10-09T06:59:01Z
dc.date.available2023-10-09T06:59:01Z
dc.date.issued2022en_US
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85136729188&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=20c4fe371b9b908d4f7e419f791331ff&sot=aff&sdt=cl&cluster=scofreetoread%2c%22all%22%2ct&sl=72&s=AF-ID%28%22Alanya+Alaaddin+Keykubat+University%22+60198720%29+AND+SUBJAREA%28MEDI%29&relpos=78&citeCnt=0&searchTerm=
dc.identifier.urihttps://hdl.handle.net/20.500.12868/2402
dc.description.abstractOBjeCTIVeS: The aim of this study was to present the clinical results of patients with Kellgren-Lawrence (KL) stage 2-4 hip osteoarthritis who were administered intra-articular corticosteroid (CS) or hyaluronic acid (HA), with or without fluoroscopy.MeTHOdS: This retrospective comparative study was conducted in the clinics where the authors worked between 2010 and 2018. Patients with stage 2-4 hip osteoarthritis according to KL criteria were included in the study. Age, body mass index, American Society of Anesthesi-ologists stages, and Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (3rd, 6th, and 12th months) were recorded. Two groups were created as patients who underwent injection with or without fluoroscopy guidance. In group 1, CS (triamnisolone) was administered, and in group 2, sodium hyaluronate 88 mg/4 mL was administered. Obtained parameters were compared.ReSulT S: The WOMAC scores at 3 months of both the CS and HA groups were statistically significantly better than before the application, with the improvement in the CS group found to be significantly better than in the HA group (P = .047). At 6 months, the mean WOMAC scores of the CS and HA groups were better than prior to the application, and there was a statistically significant difference (P< .001). No significant differ-ence was found in either the CS or HA group in the comparison of 12-month WOMAC scores with the baseline scores (P = .744 and P = .054).COnCluSIOn: In symptomatic hip OA patients, intra-articular administration of CS and HA was seen to be effective at 3 and 6 months after administration. However, the effectiveness was determined to have disappeared within 1 year. Furthermore, in hip OA intra-articular drug applications, it was determined that the blinded technique without radiological guidance performed in the outpatient clinic is as effective and safe as the radiologically guided technique administered in the operating roomen_US
dc.language.isoengen_US
dc.relation.isversionof10.1177/11795441221118920en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHip osteoarthritisen_US
dc.subjectHyaluronic aciden_US
dc.subjectCorticosteroidsen_US
dc.subjectIntra-articular injectionen_US
dc.subjectFluoroscopyen_US
dc.titleRadiologically Guided Versus Blinded Intra-articular Injection in Patients With Hip Osteoarthritis: A Retrospective Comparative Studyen_US
dc.typearticleen_US
dc.contributor.departmentALKÜ, Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.identifier.issue15en_US
dc.relation.journalClinical Medicine Insights: Arthritis and Musculoskeletal Disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster